Analysts expect Balchem Co. (NASDAQ:BCPC) to announce earnings per share of $0.84 for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for Balchem’s earnings. Balchem posted earnings of $0.77 per share in the same quarter last year, which suggests a positive year-over-year growth rate of 9.1%. The company is expected to issue its next quarterly earnings results on Thursday, February 27th.

On average, analysts expect that Balchem will report full year earnings of $3.16 per share for the current financial year. For the next fiscal year, analysts anticipate that the business will post earnings of $3.17 per share, with EPS estimates ranging from $3.07 to $3.27. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of research firms that follow Balchem.

Balchem (NASDAQ:BCPC) last issued its earnings results on Tuesday, November 5th. The basic materials company reported $0.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.74 by $0.07. The business had revenue of $158.60 million during the quarter, compared to analysts’ expectations of $166.42 million. Balchem had a return on equity of 14.01% and a net margin of 12.43%. The business’s revenue for the quarter was up 2.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.73 EPS.

Several research analysts have issued reports on BCPC shares. ValuEngine lowered Balchem from a “hold” rating to a “sell” rating in a report on Saturday, January 4th. Zacks Investment Research lowered Balchem from a “hold” rating to a “sell” rating in a report on Friday, January 3rd. BidaskClub upgraded Balchem from a “sell” rating to a “hold” rating in a report on Thursday, January 16th. Finally, HC Wainwright restated a “positive” rating and issued a $110.00 target price (up previously from $95.00) on shares of Balchem in a report on Wednesday, November 6th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $107.67.

Institutional investors and hedge funds have recently modified their holdings of the stock. Tower Research Capital LLC TRC purchased a new stake in shares of Balchem during the second quarter valued at approximately $65,000. First Mercantile Trust Co. purchased a new stake in Balchem in the third quarter worth $72,000. HM Payson & Co. purchased a new stake in Balchem in the second quarter worth $147,000. Balyasny Asset Management LLC purchased a new stake in Balchem in the second quarter worth $206,000. Finally, MML Investors Services LLC purchased a new stake in Balchem in the second quarter worth $213,000. 87.87% of the stock is owned by institutional investors.

NASDAQ:BCPC traded up $0.37 on Monday, hitting $107.38. The stock had a trading volume of 682 shares, compared to its average volume of 89,951. The business’s fifty day moving average is $103.39 and its 200 day moving average is $98.77. The company has a market cap of $3.44 billion, a PE ratio of 43.26 and a beta of 1.18. The company has a quick ratio of 2.31, a current ratio of 3.33 and a debt-to-equity ratio of 0.32. Balchem has a 52 week low of $79.06 and a 52 week high of $109.44.

The firm also recently declared an annual dividend, which was paid on Friday, January 17th. Investors of record on Monday, December 30th were given a dividend of $0.52 per share. This represents a dividend yield of 0.51%. This is an increase from Balchem’s previous annual dividend of $0.47. The ex-dividend date of this dividend was Friday, December 27th. Balchem’s dividend payout ratio (DPR) is presently 17.28%.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.

Read More: Percentage Gainers

Get a free copy of the Zacks research report on Balchem (BCPC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.